BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3559982)

  • 1. Comparative evaluation of morphine, pentazocine and ciramadol in postaddicts.
    Preston KL; Bigelow GE; Liebson IA
    J Pharmacol Exp Ther; 1987 Mar; 240(3):900-10. PubMed ID: 3559982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
    Lamas X; Farre M; Cami J
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1485-92. PubMed ID: 8138958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug discrimination in human postaddicts: agonist-antagonist opioids.
    Preston KL; Bigelow GE; Bickel WK; Liebson IA
    J Pharmacol Exp Ther; 1989 Jul; 250(1):184-96. PubMed ID: 2473187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers.
    Preston KL; Bigelow GE
    J Pharmacol Exp Ther; 1993 Feb; 264(2):813-23. PubMed ID: 7679737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the subjective, psychomotor and physiological effects of intravenous pentazocine and morphine in normal volunteers.
    Zacny JP; Hill JL; Black ML; Sadeghi P
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1197-207. PubMed ID: 9732379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
    Strain EC; Preston KL; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1993 Nov; 267(2):624-34. PubMed ID: 7504098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers.
    Jones HE; Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 1999 Jan; 288(1):188-97. PubMed ID: 9862770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
    Jones HE; Bigelow GE; Preston KL
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind comparison of multiple intramuscular doses of ciramadol, morphine, and placebo for the treatment of postoperative pain.
    Powell WF
    Anesth Analg; 1985 Nov; 64(11):1101-7. PubMed ID: 3901821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute interactions of buprenorphine with intravenous cocaine and morphine: an investigational new drug phase I safety evaluation.
    Teoh SK; Mendelson JH; Mello NK; Kuehnle J; Sintavanarong P; Rhoades EM
    J Clin Psychopharmacol; 1993 Apr; 13(2):87-99. PubMed ID: 8463453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low ceiling respiratory depression by ciramadol.
    Romagnoli A; Keats AS
    Int J Clin Pharmacol Res; 1986; 6(6):451-5. PubMed ID: 3100462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the subjective, psychomotor and physiological effects of intravenous nalbuphine and morphine in healthy volunteers.
    Zacny JP; Conley K; Marks S
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1159-69. PubMed ID: 9067299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of ciramadol (WY-15.705), morphine and placebo for treatment of postoperative pain.
    Van den Abeele G; Camu F
    Acta Anaesthesiol Belg; 1985 Jun; 36(2):97-110. PubMed ID: 3898701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans.
    Marsch LA; Bickel WK; Badger GJ; Rathmell JP; Swedberg MD; Jonzon B; Norsten-Höög C
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1056-65. PubMed ID: 11714895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers.
    Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):486-94. PubMed ID: 11160635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the cardiorespiratory effects of ciramadol, dezocine, morphine and pentazocine in the anesthetized dog.
    Lewis AJ; Kirchner T
    Arch Int Pharmacodyn Ther; 1981 Mar; 250(1):73-83. PubMed ID: 6115623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reinforcing and subjective effects of morphine in post-addicts: a dose-response study.
    Lamb RJ; Preston KL; Schindler CW; Meisch RA; Davis F; Katz JL; Henningfield JE; Goldberg SR
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1165-73. PubMed ID: 1762068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers.
    Zacny JP; Conley K; Galinkin J
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1187-97. PubMed ID: 9316825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans.
    Foltin RW; Fischman MW
    J Pharmacol Exp Ther; 1992 May; 261(2):623-32. PubMed ID: 1578376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling the subjective, psychomotor, and physiological effects of tramadol in recreational drug users.
    Zacny JP
    Drug Alcohol Depend; 2005 Nov; 80(2):273-8. PubMed ID: 16005162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.